ロード中...
Immune checkpoint blockade and CAR-T cell therapy in hematologic malignancies
Harnessing the power of the immune system to recognize and eliminate cancer cells is a longtime exploration. In the past decade, monoclonal antibody (mAb)-based immune checkpoint blockade (ICB) and chimeric antigen receptor T (CAR-T) cell therapy have proven to be safe and effective in hematologic m...
保存先:
| 出版年: | J Hematol Oncol |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6558778/ https://ncbi.nlm.nih.gov/pubmed/31186046 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13045-019-0746-1 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|